journal article·2020-01-01Open access

Osteoclastic activity was associated with the development of steroid-induced osteonecrosis of femoral head

Min-Cong He, Jin Zhang, Xiao-Jun Chen, Ying-Shan Shen, Bin Fang, Yi-Xian Qin, Wei He, Qiu-Shi Wei

Abstract

This study is focussed on evaluating and comparing two mediators of osteoclast, osteoprotegerin (OPG) and nuclear factor-κB ligand (RANKL), in plasma and tissue levels in patients with steroid-induced osteonecrosis of femoral head (SIONFH). Subjects were included in this cross-sectional case-control study in 2016. Bone histomorphology, immunohistochemistry, Western blotting, OPG and RANKL plasma levels, post-hoc statistical power and receiver-operating characteristic (ROC) curves were evaluated. Eighty-six patients diagnosed with SIONFH and 51 healthy subjects were included. OPG expression levels in bone samples increased with ARCO stage, and RANKL expression levels decreased with ARCO stages. Plasma OPG and RANKL levels were significantly higher in the SIONFH group compared with the healthy control group. The plasma OPG level and ratio of OPG and RANKL were positively associated with ARCO stages and significantly higher in stages III and IV. Plasma RANKL levels were negatively associated with ARCO stage and were significantly higher in ARCO stages II and III. Plasma OPG and RANKL may represent potential biomarkers during SIONFH at different stages. Higher plasma OPG levels indicated late-stage SIONFH, and higher plasma RANKL levels indicated early stage. Our findings may provide a clue for the development of diagnostic tools and therapies for SIONFH.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Bone and Joint Diseases · Bone health and treatments · Orthopaedic implants and arthroplasty

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

The First Affiliated Hospital of Guangzhou University of Chinese Medicine

Department of Anatomy, Guangzhou University of Chinese Medicine

First Clinical Medical College, Guangzhou University of Chinese Medicine

Department of Biomedical Engineering, Stony Brook University

Institute of Hip Joint, Guangzhou University of Chinese Medicine

Funding

This work was supported by National Natural Science Foundation of China · Natural Science Foundation of Guangdong Province

References (32)

Show source-provided references
1. Yu K, Tan H, Xu Y. [Research progress of experimental animal models of avascular necrosis of femoral head]. Zhon Xiu Chong Jian Wai Zhi. 2015;29(12):1564–1569.
2. 10.1016/j.jos.2016.03.00810.1016/j.jos.2016.03.008 ↗
3. 10.1007/s00264-018-3918-710.1007/s00264-018-3918-7 ↗
4. 10.1148/radiol.235104010010.1148/radiol.2351040100 ↗
5. 10.2106/JBJS.I.0057510.2106/JBJS.I.00575 ↗
6. Mont MA, Marulanda GA, Jones LC, et al. Systematic analysis of classification systems for osteonecrosis of the femoral head. J Bone Joint Surg Am. 2006;88(3):16–26.
7. 10.1016/j.biopha.2019.01.01310.1016/j.biopha.2019.01.013 ↗
8. 10.1016/j.cca.2018.09.01810.1016/j.cca.2018.09.018 ↗
9. 10.1007/s00264-018-3979-710.1007/s00264-018-3979-7 ↗
10. 10.1016/j.gene.2015.03.00510.1016/j.gene.2015.03.005 ↗
11. 10.1007/s00198-015-3029-x10.1007/s00198-015-3029-x ↗
12. 10.1007/s00198007002810.1007/s001980070028 ↗
13. 10.1016/j.coph.2005.06.00510.1016/j.coph.2005.06.005 ↗
14. 10.1016/S0092-8674(00)81569-X10.1016/S0092-8674(00)81569-X ↗
15. 10.1016/j.molmed.2005.11.00710.1016/j.molmed.2005.11.007 ↗
16. 10.1196/annals.1443.01610.1196/annals.1443.016 ↗
17. 10.1016/j.mporth.2013.02.00710.1016/j.mporth.2013.02.007 ↗
18. 10.1016/j.transproceed.2005.12.06210.1016/j.transproceed.2005.12.062 ↗
19. 10.1007/s00776020010810.1007/s007760200108 ↗
20. 10.1002/jcla.2148210.1002/jcla.21482 ↗
21. 10.1155/2018/635478710.1155/2018/6354787 ↗
22. 10.1371/journal.pone.009636110.1371/journal.pone.0096361 ↗
23. 10.1016/S0736-0266(02)00261-910.1016/S0736-0266(02)00261-9 ↗
24. 10.1359/JBMR.04050910.1359/JBMR.040509 ↗
25. 10.1016/j.bone.2014.12.06010.1016/j.bone.2014.12.060 ↗
26. 10.2106/JBJS.M.0136110.2106/JBJS.M.01361 ↗
27. 10.1161/01.RES.00000175571.53833.6c10.1161/01.RES.00000175571.53833.6c ↗
28. 10.1371/journal.pone.006411810.1371/journal.pone.0064118 ↗
29. 10.1302/0301-620X.85B8.1331110.1302/0301-620X.85B8.13311 ↗
30. Miao Q, Hao S, Li H, et al. Expression of osteoprotegerin, RNAK and RANKL genes in femoral head avascular necrosis and related signaling pathway. Int J Clin Exp Pathol. 2015;8(9):10460–10467.
31. 10.1016/j.yexmp.2013.10.01410.1016/j.yexmp.2013.10.014 ↗
32. Xiong MY, Liu LQ, Liu SQ, et al. Effects of osteoprotegerin, RANK and RANKL on bone destruction and collapse in avascular necrosis femoral head. Am J Translat Res. 2016;8(7):3133–3140.